CLGN icon

CollPlant Biotechnologies

18 hedge funds and large institutions have $8.55M invested in CollPlant Biotechnologies in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

31% less capital invested

Capital invested by funds: $12.5M → $8.55M (-$3.92M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$41.5K
2 +$5.5K
3 +$34

Top Sellers

1 -$35.3K
2 -$23.5K
3 -$5.89K
4
UBS Group
UBS Group
Switzerland
-$4.78K
5
First Manhattan
First Manhattan
New York
-$816
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.25M
2
$2.66M
3
$1.67M
4
$417K
5
$254K
6
$130K
7
$47.7K
8
$40.7K
9
$31.7K
10
$20.1K
11
$8K
12
$4.22K
13
$2.79K
14
$1.42K
15
$1.35K
16
$674
17
$34
18